4//SEC Filing
Fairman Jeff 4
Accession 0001209191-23-000968
CIK 0001649094other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:33 PM ET
Size
7.7 KB
Accession
0001209191-23-000968
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
Fairman Jeff
VP, Research
Transactions
- Award
Stock Option (Right to Buy)
2022-12-30+15,000→ 15,000 totalExercise: $47.95Exp: 2032-12-30→ Common Stock (15,000 underlying)
Holdings
- 17,827
Common Stock
- 286,227(indirect: By Trust)
Common Stock
- 50,000(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Includes 684 shares acquired under the Issuer's Employee Stock Purchase Plan on November 17, 2022.
- [F2]1/48 of shares subject to the option vest on January 30, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date.
Documents
Issuer
Vaxcyte, Inc.
CIK 0001649094
Entity typeother
Related Parties
1- filerCIK 0001813800
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 4:33 PM ET
- Size
- 7.7 KB